70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle ...

Data on cell-targeted LNP (ctLNP) in vivo delivery of therapeutic transgenes to T cells to be discussed in an oral presentation on Saturday, May 11 CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- ...

Generation Bio has lost around 70% of its value in the past two years because of the high risks associated with its non-viral gene therapy. The company has pivoted to focus on targeted lipid ...

CAMBRIDGE, MASS., March 13, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co (GBIO). (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune ...